Akero Therapeutics Inc (AKRO)
31.20
+0.56
(+1.84%)
USD |
NASDAQ |
Nov 21, 16:00
31.22
+0.02
(+0.06%)
Pre-Market: 20:00
Akero Therapeutics Shareholders Equity (Quarterly): 738.32M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 738.32M |
| June 30, 2024 | 798.07M |
| March 31, 2024 | 846.25M |
| December 31, 2023 | 535.31M |
| September 30, 2023 | 583.14M |
| June 30, 2023 | 616.44M |
| March 31, 2023 | 306.34M |
| December 31, 2022 | 326.56M |
| September 30, 2022 | 343.51M |
| June 30, 2022 | 148.37M |
| March 31, 2022 | 146.54M |
| December 31, 2021 | 169.11M |
| Date | Value |
|---|---|
| September 30, 2021 | 198.63M |
| June 30, 2021 | 220.13M |
| March 31, 2021 | 246.02M |
| December 31, 2020 | 258.71M |
| September 30, 2020 | 286.46M |
| June 30, 2020 | 103.66M |
| March 31, 2020 | 118.32M |
| December 31, 2019 | 128.73M |
| September 30, 2019 | 143.38M |
| June 30, 2019 | 158.39M |
| March 31, 2019 | 69.66M |
| December 31, 2018 | -49.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
103.66M
Minimum
Jun 2020
846.25M
Maximum
Mar 2024
355.93M
Average
272.58M
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 777.16M |
| 89bio Inc | 378.10M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 817.55M |
| Total Liabilities (Quarterly) | 79.22M |